The recent revelation that nearly 20% of tested chemotherapy drugs failed basic quality standards is more than just alarming. It is a global public health crisis with devastating consequences, ...

Learn more about the research of Mayo Clinic's Gene Editing and Cellular Engineering Laboratory led by David (Chun-Wei) D.

Thailand has introduced its first domestically created targeted therapy pill for cancer treatment, named Imcranib 100.

Indian oranges matched the former Spanish and Mexican counterparts. 2,000 metric tons of small oranges were procured in the ...

US state department issues first of 1,350 termination orders after court lifted ban ‘Days of Our Lives' Star Susan-Seaforth Hayes Reacts To Daytime Emmy Snub For Episode Involving Late Husband: ...

Navigating 2025 Drug Pricing Policies webinar, panelists discussed the Most Favored Nation executive order, bills aimed at ...

First Bispecific Antibody Drug Conjugates Commercial Approval Expected By 2029 Says Kuick Research. Delhi, July 11, 2025 (GLOBE NEWSWIRE) -- Global Bispecific Antibody Drug Conjug ...

The FDA granted fast track designation to TRE-515 plus radioligand therapy for treating PSMA-positive metastatic ...

Scientists have discovered a protein that acts like a “suit of armour” for skin cancer cells in a breakthrough that could ...

The FDA has approved a groundbreaking new therapy for patients battling late-stage melanoma, offering hope when options run out.

AL amyloidosis is caused by abnormal plasma cells in the bone marrow, which produce misfolded amyloid proteins that circulate in the blood, then build-up in the heart, kidney, liver, and other organs.

According to CEL-SCI, the SFDA typically responds to Breakthrough Medicine Designation applications within approximately 60 days. The company stated that several Saudi funds have expressed interest in ...